CIRG
 |
|
|
 |
Press Releases
- CIRG Press Release on FDA approval for the TCH arm used in its BCIRG 006 study
CIRG Press Release May 29 2008
CIRG Press release French version
-
BETH (TRIO-CIRG 011) Open to enrollment
BETH press release May 27 2008 (english version)
- San Antonio 2005
- BCIRG/Sanofi Aventis BCIRG006 Press Release Dec 08 2005
- BCIRG/Sanofi Aventis BCIRG006 communiqué de presse en français
- BCIRG 006
"BCIRG 006 Interim Analysis of more than 3,000 patients...":
- BCIRG/Sanofi Aventis BCIRG006 Press Release Sept 14 2005
- BCIRG/Sanofi Aventis BCIRG006 communiqué de presse 14 sept 2005
- Genentech Press Release dated Sept 13, 2005
-
BCIRG 001:
June 2, 2005 Publication of BCIRG001 study in the
New England Journal of Medicine
>>> CIRG Press Release BCIRG001 - June 2005
U.S FDA to approve docetaxel (Taxotere) in combination with doxorubicin and cyclophosphamide (TAC) for the Adjuvant Treatment of Women with node-positive Early-Stage Breast Cancer:
BCIRG Press Release August 19 2004.
BCIRG Press Release August 19 2004.
BCIRG 001 second interim analysis results released in San Antonio Breast Cancer Conference on December 5, 2003 Click here to access to the Latest information
BCIRG 001 Study Interim Analysis: Press Release May 19, 2002 : BCIRG001 Press Release
